OBN Announces New Health and Life Sciences Event in Partnership with the West Sussex Health and Life Sciences Cluster
The first BioTuesday™ event in West Sussex will take place on 6 December at 6.30pm at the Holiday Inn, Gatwick, and will cover 'The sources of public non-dilutable funding and export support to UK R&D companies'. There will be several high-quality presentations from leading experts in the field followed by a panel discussion and networking over wine and canapés.
West Sussex has a booming health and life sciences sector; from world renowned medical and diagnostic technology companies to major pharmaceuticals and industry support services. The county is home to more than 120 diverse companies, contributing to the forefront of innovation in the global health and life sciences sector.
WSHLSC, supported by West Sussex County Council, and its partners are focused on building the sector to position West Sussex as a leading place on the national and international stage for businesses to start, thrive and locate, with a key drive being the creation and retention of high value jobs.
Dr John Harris, CEO of OBN, said: "We are delighted to be working with West Sussex County Council on this exciting event. Life science organisations prosper when embedded within recognised clusters with an integrated support system and dynamic business networks. Our joint goal for this event is to support both our existing OBN membership base in the region and the companies within the West Sussex Health and Life Sciences Cluster whilst encouraging new companies to view West Sussex as an attractive region in which to establish and grow their life sciences businesses."
Louise Goldsmith, Leader of WSCC, commented: "The health and life sciences sector is a key sector in West Sussex and we are strongly committed to supporting its ground-breaking research through the establishment of the West Sussex Health and Life Sciences Cluster, a cluster that will spread innovation throughout the regional life sciences ecosystem by creating a sustainable platform for networking and knowledge transfer. We want to help grow and support the sector and put West Sussex on the map as a major hub for life sciences.
"This event will help bring companies together to galvanise our cluster, facilitate interaction and provide networking opportunities in the wider region."
Click here for further event information and registration.
Free PCI Breakfast Seminar - Find Out How to Get Your Investigational Products in the Clinic Quicker
Scaling the new frontier - PCI recognises that biologically derived therapeutic products are the new frontier, heralding revolutionary treatments of a number of diseases and injuries. These therapies traditionally have widely varying development requirements and ensuring a swift yet robust supply chain process is critical to the integrity of the products. PCI and their partners Greenaway Scott provide market leading services for products requiring this expedited delivery. Join them at Oxford Science Park on 13 October for the latest of the PCI Clinical Seminar series and hear from their experts. This seminar will consider how pharmaceutical businesses can make the most of investments and what a fund raising round involves, why it is important to protect your intellectual property and how businesses can secure customers using tailored trading agreements which are appropriate for use in the pharmaceutical industry.
It will also look at how the exponential growth and the predicted future growth of Biologics has increased the need for cold chain packaging. The session will address how Fast Track can be beneficial during smaller trials where data is needed as quickly as possible compromising on quality.
Finally, where time is of the essence, speed to clinic should not be at the expense of poor packaging design. By looking ahead and forward planning your packaging partner and dosing strategy, high compliance packaging solutions are possible.
Open Science and Innovation Impacts for Life Sciences Companies
The next OBN Senior Executive Breakfast in Oxford on the 20 October is entitled "How will the growth of open science and innovation impact the funding landscape for life sciences companies?" It will be hosted by Penningtons Manches at their Oxford Business Park offices.
Andrew McLean from Oxford Science Innovation and Tom Britton, co-founder of SyndicateRoom, will provide their views and comments on developments around funding for life science companies, and then join a round table discussion.
